Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jun;13(6):331-339.
doi: 10.1038/nrrheum.2017.15. Epub 2017 Mar 9.

Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis

Affiliations
Review

Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis

Leendert A Trouw et al. Nat Rev Rheumatol. 2017 Jun.

Abstract

The presence of autoantibodies is one of the hallmarks of rheumatoid arthritis (RA). In the past few decades, rheumatoid factors (autoantibodies that recognize the Fc-tail of immunoglobulins) as well as anti-citrullinated protein antibodies (ACPAs) have been studied intensively. ACPAs recognize post-translationally modified proteins in which the amino acid arginine has been converted into a citrulline. More recently, other autoantibody systems recognizing post-translationally modified proteins have also gained attention, including autoantibodies recognizing fragmented immunoglobulin (anti-hinge antibodies), autoantibodies recognizing acetylated proteins and autoantibodies recognizing proteins that are modified by adducts formed under oxidative stress. In particular, detailed insights have been obtained on the presence and properties of autoantibodies recognizing carbamylated proteins, commonly called anti-carbamylated protein (anti-CarP) antibodies. In this Review, we summarize the current knowledge relating to these emerging autoantibodies that recognize post-translationally modified proteins identified in RA, with an emphasis on anti-CarP antibodies.

PubMed Disclaimer

References

    1. Free Radic Biol Med. 2015 Dec;89:409-18 - PubMed
    1. Ann Rheum Dis. 2010 Sep;69(9):1580-8 - PubMed
    1. Rheumatology (Oxford). 2016 Apr;55(4):764-6 - PubMed
    1. Clin Chim Acta. 2016 Sep 1;460:5-10 - PubMed
    1. Clin Chem. 2011 Nov;57(11):1499-505 - PubMed

MeSH terms